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The acrosome reaction, the first step of the fertilization, is induced by calcium influx through Canonical Transient Receptor Potential
channels (TRPC). The molecular nature of TRPC involved is still a debated question. In mouse, TRPC2 plays the most important role and is
responsible for the calcium plateau. However, TRPC1 and TRPC5 are also localized in the acrosomal crescent of the sperm head and may
participate in calcium signaling, especially in TRPC2-deficient mice. Activation of TRPC channels is an unresolved question in germ and
somatic cells as well. In particular, in sperm, little is known concerning the molecular events leading to TRPC2 activation. From the
discovery of IP3R binding domains on TRPC2, it has been suggested that TRPC channel activation may be due to a conformational coupling
between IP3R and TRPC channels. Moreover, recent data demonstrate that junctate, an IP3R associated protein, participates also in the gating
of some TRPC.
In this study, we demonstrate that junctate is expressed in sperm and co-localizes with the IP3R in the acrosomal crescent of the anterior
head of rodent sperm. Consistent with its specific localization, we show by pull-down experiments that junctate interacts with TRPC2 and
TRPC5 but not with TRPC1. We focused on the interaction between TRPC2 and junctate, and we show that the N-terminus of junctate
interacts with the C-terminus of TRPC2, both in vitro and in a heterologous expression system. We show that junctate binds to TRPC2
independently of the calcium concentration and that the junctate binding site does not overlap with the common IP3R/calmodulin binding
sites.
TRPC2 gating is downstream phospholipase C activation, which is a key and necessary step during the acrosome reaction. TRPC2 may
then be activated directly by diacylglycerol (DAG), as in neurons of the vomeronasal organ. In the present study, we investigated whether DAG
could promote the acrosome reaction. We found that 100 AM OAG, a permeant DAG analogue, was unable to trigger the acrosome reaction.
Altogether, these results provide a new hypothesis concerning sperm TRPC2 gating: TRPC2 activation may be due to modifications of its
interaction with both junctate and IP3R, induced by depletion of calcium from the acrosomal vesicle.
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The acrosome reaction (AR), the first step of fertilization,
is an exocytotic event allowing sperm to cross the zona
pellucida and to become competent for fusion with the86 (2005) 326 – 337
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AR is regulated by a multifaceted intracellular calcium rise.
This calcium increase is due to the consecutive openings of
three different types of calcium channels: (i) a voltage
activated channel, (ii) the inositol 1,4,5-triphosphate recep-
tor (IP3R) and finally (iii) a store-operated channel. The first
channel type to be activated is on the plasma membrane,
belongs to the low-voltage activated calcium channels
family (Arnoult et al., 1996), and our recent data strongly
suggest that this channel is a CaV3.2 channel (Stamboulian
et al., 2004). This channel is activated few hundred of
milliseconds after the binding of the zona pellucida
glycoprotein ZP3 on its yet uncharacterized receptor and
is responsible of a short calcium transient (Arnoult et al.,
1999). The role of the transient calcium entry via CaV3.2
channel is still a matter of debate. It may modulate other
calcium channels involved in the downstream intracellular
calcium rise (Stamboulian et al., 2002). The second channel
type to be activated is the intracellular IP3R, present in the
outer membrane of the sperm acrosome (Walensky and
Snyder, 1995), contrary to other cell types where it is
present in the endoplasmic reticulum. Then, the acrosome,
known to be a vesicle of secretion, plays also a role as a
calcium store (De Blas et al., 2002; Herrick et al., 2004).
ZP3 activates, via a G protein, a phopholipase C (PLC), an
enzyme that produces two secondary messengers, inositol
1,4,5-triphosphate (IP3) and diacylglycerol (DAG). PLC
activation is a necessary step since inhibitors of PLC block
the AR (O’Toole et al., 2000). The production of IP3 by
PLC activates IP3R and leads to the emptying of the specific
sperm calcium store, the acrosome. Finally, the third
channel, a store-operated calcium channel (SOC), is
activated.
Store-operated calcium channels are activated by the
depletion of intracellular calcium stores. In vertebrates, the
seven members of TRPC proteins (TRPC1–7) are proposed
to be classical representatives of these channels (Montell,
2001). In sperm, different types of TRPC channels are
present such as TRPC1, 2, 3 and 5 (Castellano et al., 2003;
Jungnickel et al., 2001; Sutton et al., 2004; Trevino et al.,
2001). Among them, it is accepted that TRPC2 plays the
major role during the mouse acrosome reaction because
specific inhibition of TRPC2 blocks the slow calcium rise
and the sperm exocytosis (Jungnickel et al., 2001).
However, TRPC2-deficient mice do not present fertility
troubles (Stowers et al., 2002), suggesting that other
members of the TRPC family present in sperm may be
up-regulated to compensate the lack of TRPC2. TRPC1 and
TRPC5 are potentially able to compensate the lack of
TRPC2 since their cellular localization overlaps perfectly
the acrosomal crescent (Sutton et al., 2004).
The mechanism of activation of SOC is still a matter of
debate. To summarize, three different ways of activation
have been described: (1) SOC are activated via secondary
messenger like Calcium Influx Factor (CIF) (Randriamam-
pita and Tsien, 1993), (2) SOC activation depends on someextent on exocytosis (Yao et al., 1999) and (3) the IP3R,
localized vis a vis the plasma membrane in microdomains of
the ER, interacts with SOC, allowing its direct activation
after calcium store emptying (Kiselyov et al., 1998), in a
mechanism similar to what already described for the
coupling between ryanodine receptor and the dihydropyr-
idine receptor in skeletal muscle cells. This latest mode of
gating was clearly demonstrated only for TRPC channels. In
agreement with the third hypothesis, we have recently
shown that TRPC3 activation is modulated by junctate, an
endoplasmic membrane protein which is a partner of the
IP3R (Treves et al., 2004). TRPC3 current amplitude
induced by carbachol perfusion is strongly reduced by
dialysis of a peptide encompassing the N-terminus of
junctate via a patch pipette. Because the lumen part of the
junctate has calcium binding domains, it has been hypothe-
sized that junctate could be the sensor of store depletion and
that structural modification of junctate may be the first
molecular event leading to TRPC3 activation. Finally, it is
important to point out that some TRPC channels are not
activated by calcium store depletion but rather by DAG and,
to complicate the debate, that a same type of TRPC channel
can be activated in different ways depending on its tissues
distribution or density expression (Vazquez et al., 2003).
The TRPC2 Ca2+-permeable channel is a functional
channel in rodent (Vannier et al., 1999), specifically
expressed in vomeronasal organ where it plays a key role
in pheromone detection (Stowers et al., 2002), in testis
where it plays a key role in AR (Jungnickel et al., 2001) and
in erythroblast where it controls erythropoietin-induced
differentiation and proliferation (Chu et al., 2002). Bio-
chemical results demonstrating the presence of IP3R bind-
ing sites on TRPC2 strongly suggest that TRPC2 could be
activated by a direct interaction with IP3R (Tang et al.,
2001). However, the mode of activation of TRPC2 appears
quite variable depending on the cell type considered. In
neurons of the vomeronasal organ, TRPC2 is clearly
activated directly by DAG, independently of the IP3R
activation (Lucas et al., 2003). On the other hand, in
erythroblast, the TRPC2 activation requires a functional
interaction with IP3R since mutations of the known binding
sites on TRPC2 for IP3R lead to an inhibition of TRPC2
activation by erythropoietin (Tong et al., 2004). In contrast
to these cell types, the mechanism of activation of TRPC2 in
sperm is less understood. It has been shown that IP3R and
TRPC2 are localized in the same sperm region, the
acrosomal crescent (Jungnickel et al., 2001). Moreover,
calcium release via IP3R is necessary for Rab3-activated
acrosome reaction (De Blas et al., 2002), and, finally, the
calcium entry induced by thapsigargin, a classical inhibitor
of SERCA type calcium ATPase, is inactivated by specific
antibodies against TRPC2 (Jungnickel et al., 2001), sug-
gesting that the acrosomal calcium emptying is sufficient to
activate TRPC2. These results, taken together, suggest that
the store depletion via IP3R activation is an important step
in TRPC2 activation.
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involving TRPC channels in heterologous expression
systems (Treves et al., 2004), we decided to investigate
the presence of junctate in sperm. In order to evaluate its
potential involvement in sperm calcium signaling during
acrosome reaction, we explored the possibility for junctate
to be a molecular partner of TRPC channels putatively
involved in AR, that are TRPC1, TRPC2 and TRPC5.
In this paper, we show that junctate is present in mouse
and rat sperm and is localized in the acrosomal crescent of
the anterior sperm head. Junctate is not only an IP3R
associated protein but binds also directly on TRPC2, a
TRPC involved in AR and on TRPC5, a TRPC over-
lapping the acrosomal crescent. On the other hand,
TRPC1, also present in the acrosomal crescent, does not
bind junctate. We show that the amino-terminal domain of
junctate interacts with the carboxyl-terminal domain of
TRPC2 (TRPC2-Cter). The binding site of junctate on
TRPC2 is different than (1) the IP3R binding site (named
also CIRB for Calmodulin IP3R Binding site) described
earlier (Tang et al., 2001) and (2) the calmodulin binding
sites. The presence of junctate in the acrosomal region, the
biochemical evidences that junctate and TRPC2 are able to
interact tightly, and the fact that DAG does not promote
acrosome reaction provides new hypothesis concerning
TRPC2 activation in sperm: TRPC2 activation may be due
to modifications of its interaction with both junctate and
IP3R, induced by depletion of calcium from acrosomal
vesicle.Material and methods
Cell culture and transfection
HEK-293 cells were grown in Dulbecco’s Modified
Eagle’s Medium (DMEM, Invitrogen) supplemented with
10% FBS (Invitrogen) and 1% penicillin/streptomycin and
transiently transfected with pEGFP-junctate, TRPC1 or
TRPC5 containing plasmids, using JetPEI from Qbiogene
according to the instructions of the manufacturer. Two days
after transfection, transfected and control cells were
collected and re-suspended in RIPA buffer (50 mM Tris
pH 7.5, 150 mM NaCl, 0.1% SDS, 1% NP 40, 0.5% DOC)
complemented with a cocktail of protease inhibitors
(Complete Mini, EDTA-free, Roche).
Acrosomal membrane preparation
Sperm were obtained from OF1 mice (16 weeks old,
Charles River) by manual trituration of caudae epididymis.
To obtain an acrosomal-membraneenriched fraction,
sperm were capacitated in M2 (Sigma) supplemented with
BSA (20 mg/ml, pH 7.4) for 1 h at 37-C. Sperm were
pelleted (500 g, 10 min) and treated with 10 AM A23187
during 30 min at 37-C in the presence of a cocktail ofprotease inhibitors. Sperm were then centrifuged 5 min at
1000  g. The supernatant was collected and subsequently
ultra-centrifuged at 100,000  g for 1 h at 4-C. The pellet
was re-suspended in RIPA buffer containing: 50 mM Tris
pH 7.5, 150 mM NaCl, 0.1% SDS, 1% NP 40, 0.5% DOC,
complemented with a cocktail of protease inhibitors
(Complete Mini, EDTA-free, Roche).
DNA construct
Expression of the recombinant proteins
A His-tag (6 His) fusion protein, starting three amino
acids before the TRP box, containing the full COOH-
terminal domain of TRPC2 was obtained as follows: a 747
bp cDNA corresponding to amino acid residues 925–1172
(NM_011644) was obtained by PCR using the following
primers: forward primer 5V-CATGCCATGGTCAAGCTT-
CAGAAGATCGAGGATGATGCTG-3V and reverse primer
5V-GCTTCTAGAGTTAGGACTCGCCCTTGGTCTC-
CAG-3. This construct was then inserted in frame into the
multiple cloning sites of the His-tag pMR78 vector (Arnaud
et al., 1997) and verified by sequencing. The His-tag is
located at the N-terminus of the fusion protein. The
recombinant plasmid was then transformed into E. coli
BL 21 (Invitrogen) in order to express the His-TRPC2-Cter
fusion protein. The fusion protein was purified with an Ni-
NTA agarose column (Qiagen) according to the instructions
of the manufacturer.
GFP-junctate was constructed as previously described
(Treves et al., 2004).
RT-PCR amplification
Messenger RNA from adult mice testes and brains was
prepared from tissue with the Dynabeads isolation kit
(Dynal). Each RT-PCR reaction was performed in a total
volume of 25 Al in the presence of 30 ng of mRNA using
the Superscript TM One step RT-PCR system (Invitrogen).
Sense and reverse primers were respectively 5V-TTTT-
GTGCATGGATTGAAGAA-3V (nucleotides 40–61 of junc-
tate AF302653) and 5V-TCGACCAAGTCAAACCACAC-
3V (nucleotides 130–149 of junctate). Reverse transcription
was achieved within 30 min of incubation at 45-C.
Amplification was obtained after 40 cycles of temperature:
30 s at 94-C, 30 s at 48-C and 30 s at 72-C. Elongation was
done at 72-C during 10 min.
A 185 bp product was obtained in both tissues and
purified using Nucleospin (Macherey Nagel). These cDNA
products were amplified in the same conditions as above
and subsequently sequenced.
As control for the mRNA preparation and quantification,
a 192 bp cDNA product from Hypoxanthine Phospho
Ribosyl Transferase (HPRT) cDNAwas amplified using the
forward primers 5V-TGTAATGACCAGTCAACAGGG-3V
and the reverse primer 5V-TGGCTTATATCCAACACTT-
CG-3 (data not shown).
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Proteins were separated on 12% polyacrylamide denatur-
ing gels and electro-transferred for 90 min at 350 mA to
Immobilon P transfer membrane (Millipore). The mem-
branes were then blocked 60 min with 4% non-fat dry milk
(Biorad) in PBS Tween 0.1%. The primary antibody was
added and incubated overnight at 4-C. After washing in
PBS Tween 0.1%, the secondary antibody (anti-rabbit
Jackson lab.) was added at 1:10,000 during 3 h at room
temperature. The membrane was washed and incubated 1
min in HRP substrate (Western Lightning, Perkin-Elmer
Life Science). The reactive proteins were detected using
chemiluminescence assay followed by exposure to Biomax
film (Kodak).
The presence of junctate in sperm membrane fraction and
in acrosomal enriched fraction was tested using antibody
raised against its carboxyl-terminus (Treves et al., 2000) at a
final concentration of 1 Ag/ml.
Antibodies against green fluorescent protein (GFP)
(Santa Cruz Biotechnology) was used to purify junctate
during immunoprecipitation and for Western blotting diluted
at 1:5000.
Monoclonal anti-polyhistidin (Sigma) was used at a
dilution of 1:10,000.
Antibodies against TRPC1 and TRPC5 were from
Alomone.
Immunoprecipitation and pull-down experiments
Immunoprecipitation of TRPC2-Cter with GFP-junctate
GFP antibody (0.8 Ag/ml) was incubated with protein A
(Dynabeads Protein A, Dynal) 30 min at room temperature.
Beads were rinsed with 50 mM Tris, 100 mM NaCl, 5 mM
CaCl2, 5 mM EGTA (free calcium concentration = 10 AM)
pH 7.5, three times and incubated overnight with total
protein extracts from HEK-293 cells transiently transfected
with pEGFP-junctate (Treves et al., 2004). After three
washes, beads were incubated with the fusion protein
TRPC2-Cter containing the His-tag during 2 h at 4-C.
Beads are then washed five times, and bound proteins were
eluted by boiling 5 min at 95-C in Laemmli sample buffer.
Control was performed with total protein extract from
untransfected HEK-293 cell.
Immunoprecipitation of TRPC2-Cter, TRPC5 and TRPC1
with biotinylated junctate peptide on streptavidin beads
Biotinylated peptide corresponding to the amino-termi-
nus of junctate (MAEDKETKHGGHKNGRKGGLSGT-
SK–biotin) or biotin was incubated 30 min at room
temperature with streptavidin beads (Dynabeads M280
Streptavidin, Dynal).
Beads were washed three times with a buffer containing
in mM: Tris 50 pH 7.5, NaCl 100, CaCl2 5, EGTA 5 and
100 AM or 10 nM free Ca2+. Beads were blocked during 1 h
with BSA (0.2 mg/ml) and then incubated with purified His-TRPC2-Cter or with total protein extracts from HEK-293
cells transiently transfected with plasmids containing
TRPC1 or TRPC5 overnight at 4-C in the presence of a
cocktail of protease inhibitors (Complete Mini, EDTA-free,
Roche). Beads were washed two times, and bound proteins
were eluted by boiling 5 min in Laemmli sample buffer.
Immunoprecipitation of TRPC2-Cter with
calmodulin–sepharose beads
Calmodulin–sepharose 4B (Amersham Biosciences) was
incubated 45 min with TRPC2-Cter diluted in a solution
containing in mM: Tris 50 pH 7.5, NaCl 100, CaCl2 5,
EGTA 5 and BSA 2 mg/ml. Bound proteins were eluted by
boiling 5 min in Laemmli sample buffer.
For competition studies, F2q peptide (amino acids 669–
698 of IP3R) was synthesized by Neosystem-Strasbourg F.
Immunohistochemistry and indirect immunofluorescence
Sperm were harvested from the caudae epididymis,
washed in PBS and fixed in 4% PFA for 30 min on ice.
Fixed sperm were allowed to air-dry on poly-l-lysine-
coated slides. The slides were washed in PBS (3  5 min),
50 mM NH4Cl (2  15 min), PBS (3  5 min), 0.1% triton
X-100 (15 min) and PBS (3  5 min). Slides were blocked
with 1% BSA and 2% normal goat serum during 60 min at
room temperature. Slides were incubated overnight at 4-C,
in the presence of an antibody against junctate (Treves et al.,
2000) and/or an antibody against IP3R (gift from Dr.
Mikoshiba Tokyo-Japan), diluted in the blocking solution at
1/100 and 1/2000 respectively. Slides were then incubated
60 min with a secondary antibody (Alexa fluor 546 or Alexa
fluor 488—Molecular probes), diluted at 1/800 and washed
in PBS (3  5 min). Slides were analyzed on a confocal
laser scanning microscope (Leica TCS-SP2, Mannheim).
BIAcore analysis
Real time surface plasmon resonance (SPR) experiments
were performed on a BIAcore biosensor system 1000 at
25-C with a constant flow rate of running buffer 100 AM
free calcium (50 mM Tris pH 7.5, 100 mM NaCl, 5 mM
CaCl2, 5 mM EGTA) or with a buffer containing 10 nM free
calcium (50 mM Tris pH 7.5, 100 mM NaCl, 5 mM EGTA).
Biotinylated junctate peptide or biotin was immobilized on
the sensor chip surface coated with streptavidin (sensor chip
SA). Various concentrations of purified TRPC2-Cter were
injected onto the coupled surfaces. Regeneration of the
sensor chip for subsequent injections was accomplished by
injecting SDS 0.01%, 0.02% and 0.03%.
Acrosome reaction assays
Sperm were harvested from OF1 mice and allowed to
swim in M2 medium for 10 min. Sperm were then
capacitated for 45 min at 37-C in M16 medium containing
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reaction (A23187, OAG) were added in the capacitation
medium, and sperm were incubated for further 30 min.
Sperm were then fixed in 4% PFA and stained with
coomassie blue.
M2 and M16 medium, 1-oleoyl-2-acetyl-sn-glycerol
(OAG) and A23187 were from Sigma.Results
Junctate is present in rodent sperm and localized in the
acrosomal crescent of the anterior sperm head
Because IP3 production was shown to be necessary for
acrosome reaction and junctate was shown to be an
important regulating protein of IP3R-dependent calcium
influx, we decided to seek this protein in mature sperm
cells. Three different approaches have been used to
demonstrate the presence of junctate in sperm. First, we
checked the presence of junctate in mouse testis by RT-
PCR, using a sense primer designed in the non-codant
amino-terminal part of the protein and an antisense primer
spanning across transmembrane and luminal part of the
protein. The PCR product amplified from mRNA has a
size of 180 bp, as expected (Fig. 1A). Identity of the
product was confirmed by sequence analysis of the band
(data not shown).
Our second approach was to demonstrate the presence
of the protein junctate by Western blot using a polyclonalFig. 1. Junctate is present in sperm. (A) cDNA products obtained after RT-
PCR from brain (B) and testis (T) poly A mRNA, using junctate-specific
primers. The testis 185 bp product sequence aligns with junctate sequence
(data not shown). (B) Western blot showing the presence of junctate in a
membrane fraction enriched with outer acrosomal membrane from mouse
and rat sperm, using anti-junctate-specific antibody. On the left, visual-
ization of proteins standards (lane truncated) used to estimate the molecular
weight.antibody (Treves et al., 2000). Junctate, as IP3R, is
generally present in the endoplasmic membranes. How-
ever, in mature sperm cells, where the endoplasmic
reticulum is absent, endoplasmic membrane proteins like
IP3R are localized in the acrosomal membrane. Thus,
membrane preparation enriched in acrosomal membrane
should present a higher concentration of junctate than in a
sperm crude membrane extract. To obtain a membrane
preparation enriched with outer acrosomal membranes,
capacitated sperm were treated with the calcium ionophore
A23187 to promote AR. Secretion vesicles, corresponding
to plasma membrane and outer acrosomal membranes
merged together, were purified by centrifugation (see
Material and methods section) and the presence of
junctate studied by Western blot analysis (Fig. 1B). For
mouse sperm, 3 bands were stained with apparent
molecular weight (MW) of 41, 43 and 45 kDa respec-
tively. We also checked the presence of junctate in similar
membrane preparation obtained from rat sperm. In rat, the
antibody immunodecorated only one band at 43 kDa (Fig.
1B). The 3 bands observed in mouse preparation likely
correspond to different isoforms of junctate. Three
junctate isoforms have indeed already been described in
mouse cardiac cells with apparent molecular weight
between 40 and 53 kDa.
The acrosomal localization of junctate was confirmed by
immunostaining experiments of rat and mouse sperm cells.
In both species, the polyclonal antibody against junctate
stained the acrosomal crescent of the anterior sperm head
(Figs. 2A–B). Such result is particularly interesting since
the IP3R was shown to be localized in the same subcellular
area (Walensky and Snyder, 1995). We, then, performed co-
localization experiments using antibodies directed against
IP3R and junctate. Figs. 2C–F show that both proteins co-
localize in the same subcellular area, i.e. the acrosomal
crescent.
Altogether, these results demonstrate that junctate is
present in sperm and sub-localized in the acrosomal crescent
of the anterior sperm head, in the vicinity of the IP3R.
The presence of junctate in the sperm acrosomal region
and the facts that junctate (1) binds to TRPC3 in HEK-293
cells and (2) regulates TRPC3-dependent calcium influx
induced by carbachol (Treves et al., 2004) raise the question
of a direct interaction of junctate with the different TRPC
involved in AR (i.e. TRPC2) or overlapping the acrosomal
crescent (i.e. TRPC1 and TRPC5).
Junctate binds to the carboxyl-terminus of TRPC2
Junctate tagged by GFP was expressed in HEK-293 cells.
As expected, in a Western blot, an antibody against GFP
immunodecorated a band around 70 kDa corresponding to
GFP-junctate (Fig. 3A). Then, expressed GFP-junctate was
immobilized on sepharose beads coated with an antibody
directed against GFP and incubated with a fusion protein
corresponding to the full carboxyl-terminus of TRPC2
Fig. 2. Junctate is present in the acrosomal crescent of the anterior head.
Immunolocalization of junctate in sperm head of mouse (A) and rat (B)
evidenced with a junctate-specific antibody. Junctate is localized in the
acrosomal crescent of the anterior head. Blue staining in rat sperm head
corresponds to the nucleus stained with TOPRO stain. Co-immunolocal-
ization of junctate (C) and IP3R (D) in the same mouse sperm head. (E)
Transmitted light image (DIC) and (F) overlay of images presented in
panels C–E showing the co-localization of both proteins.
Fig. 3. Junctate and TRPC2-Cter are partners. (A) Expression of GFP-
junctate in HEK-293 cells. Western blot using anti-GFP antibody in HEK-
293 cells. Lane 1: protein extract from non-transfected cells; lane 2: protein
extract from HEK-293 cells transfected with GFP-junctate. Antibody
against GFP immunodecorates a protein of around 65 kDa, as expected,
since GFP has a molecular weight of 27 kDa and junctate of 40 kDa. (B)
Coprecipitation of TRPC2-Cter with GFP-junctate. Protein A beads were
coated with an antibody against GFP. Then, two types of cell extracts were
incubated with the beads: one from GFP-junctate transfected HEK cells
(labeled ‘‘GFP-junctate’’) and one from non-transfected HEK cells (labeled
‘‘control’’). Finally, TRPC2 fusion protein (lane 1: Input) was incubated
overnight with the beads. Only in the presence of junctate-GFP TRPC2 was
immobilized on the beads (lane 3 bound fraction (B)), the supernatant being
depleted in TRPC2 fusion protein (lane 2, non-bound fraction (NB)). Lanes
4 and 5 correspond to the beads incubated with cell extract without GFP-
junctate. TRPC2 is present in the non-bound fraction (lane 4) and not in the
bound fraction (lane 5).
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TRPC2-Cter fusion protein was tagged with histidin
residues at its N-terminus (His-TRPC2-Cter) for purification
and was evidenced in Western blots with an antibody
against its histidin tag. Fig. 3B shows that the fusion protein
corresponding to the carboxyl-terminus of TRPC2 was
bound to immobilized GFP-junctate (Fig. 3B, lane 3),
whereas the non-bound fraction (lane 2) was highly depleted
in His-TRPC2-Cter. The bound fraction on sepharose beads
incubated with cell extracts of control HEK-293 did not
contain His-TRPC2-Cter (Fig. 3B, lane 5), all the fusion
protein being present in the non-bound fraction (lane 4). Our
result clearly demonstrates that TRPC2, and more precisely
its C-terminal cytosolic domain, physically interacts with
junctate.
The amino-terminus of junctate binds the carboxyl-terminus
of TRPC2 in a calcium-independent manner
In order to confirm the binding of junctate on TRPC2
channels and also to determine which part of junctate is
involved in this binding, a peptide, encompassing the 30
amino acids of its amino-terminus (junctate-Nter), was
synthesized because only the junctate-Nter can potentially
interact with TRPC2 since its carboxyl-terminus is lu-minal. The junctate-Nter peptide was tagged with biotin
and was attached to streptavidin-coated beads. Then, His-
TRPC2-Cter fusion proteins were incubated overnight
with the coated beads. Fig. 4A shows that beads
specifically coated with junctate-Nter peptide retained
TRPC2 fusion protein (Fig. 4A, lanes 1 and 3), whereas
beads coated with biotin only did not retain the fusion
protein (Fig. 4A, lanes 2 and 4). Because calcium is well
known to modify binding of calcium-dependent proteins,
we checked the binding of TRPC2 in two different
calcium conditions: 10 nM and 100 AM free calcium.
We show that the binding of TRPC2 on junctate is
calcium-independent since His-TRPC2-Cter binds on
junctate-Nter in the presence of 100 AM (Fig. 4A, lane
1) or 10 nM (Fig. 4A, lane 3) free calcium. We also tested
the binding of TRPC2 onto junctate in 1 mM Ca2+, an
experimental approach mimicking Ca2+ release conditions:
this calcium concentration does not modify the binding
(data not shown).
Fig. 5. Junctate binding onto TRPC1 and TRPC5. (A) TRPC5 binds onto
the C-terminus of junctate. Left: TRPC5 transiently expressed in HEK-293
cells were specifically evidenced by Western blot. Right: Western blot
showing the binding of TRPC5 on the beads, after pull down of TRPC5
with biotinylated junctate-Nter peptide immobilized on streptavidin beads.
Biotinylated junctate-Nter peptide was immobilized on streptavidin beads
and then incubated with protein extract of cells transiently transfected with
TRPC5 cDNA. Only in the presence of biotinylated junctate-Nter TRPC5
was immobilized on the beads (Lane 5 bound fraction (B)); lane 4, non-
bound fraction (NB). Lanes 2 and 3 correspond to a same cell extract
incubated with beads coated with biotin only (control experiment). In the
control experiment, TRPC5 is not retained (lane 3 bound fraction (B)); lane
2, non-bound fraction (NB). Lane 1 corresponds to cell extract (input).
TRPC5 is immunodecorated with an anti-TRPC5 antibody. (B) TRPC1
does not bind onto the C-terminus of junctate. Left: Western blot showing
expression of TRPC1 in HEK cells transiently transfected with TRPC1
cDNA. Right: Western blot showing the absence of binding of TRPC1 on
the beads, after pull down of TRPC1 with biotinylated junctate-Nter peptide
immobilized on streptavidin beads. The protocol is identical as presented in
panel A for TRPC5.
Fig. 4. The junctate amino-terminus interacts with the TRPC2 carboxyl-
terminus, and this binding is calcium-independent. (A) Western blot of the
bound fractions, showing the binding of TRPC2 on the beads, after pull
down of His-TRPC2-Cter with biotinylated junctate-Nter peptide immobi-
lized on streptavidin beads. Biotinylated junctate-Nter peptide was
immobilized on streptavidin beads and then incubated with His-TRPC2-
Cter. Beads coated with biotin only correspond to a control experiment.
His-TRPC2-Cter is immunodecorated with an anti-histidin antibody. This
experiment was done in two different calcium concentrations: 100 AM
(lanes 1 and 2) and 10 nM (lanes 3 and 4). Lanes 1 and 3 show the bound
fraction in presence of biotinylated junctate-Nter peptide on beads. Lanes 2
and 4 show the bound fraction on beads coated with biotin only (control).
Lanes are extracted from the same gel but rearranged. (B) SPR measure-
ments showing the interaction of TRPC2-Cter (at concentrations of 50 and
250 nM as indicated) with biotinylated junctate-Nter immobilized on the
surface of the matrix (total). Control traces (non-specific binding) were
obtained with biotin immobilized on the surface of the matrix in a different
flow cell and correspond to the non-specific TRPC2-Cter on the surface of
the matrix (bulk + NS). The running buffer used contained 50 mM Tris pH
7.4, 150 mM NaCl and 10 nM free calcium concentration.
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TRPC2, experiments using the surface plasmon resonance
(SPR) technique (BIAcore) have been carried out. Biotiny-
lated junctate-Nter was covalently bound on a streptavidin
matrix, and TRPC2 fusion protein was introduced in the
running buffer. Fig. 4B shows specific interaction of TRPC2
with biotinylated junctate-Nter. Control experiments have
been also carried out, using a matrix covered with only
biotin (Fig. 4B, non-specific binding). This experiment
confirms clearly that carboxyl-terminus of TRPC2 binds to
amino-terminus of junctate.
Altogether, our results show that the 30 N-terminal
amino acids of junctate are sufficient to bind to the C-
terminal domain of TRPC2 and that this interaction is
calcium-independent.Junctate binds also to TRPC5 but not to TRPC1
Because TRPC1 and TRPC5 are also expressed in a
region similar to junctate, we checked if the biotinylated
junctate-Nter peptide attached to streptavidin beads retains
specifically TRPC1 or TRPC5. By Western blot, using an
antibody directed against TRPC5, a protein of a molecular
weight of 110 kDa is specifically evidenced in HEK-293
cells transiently transfected with a plasmid containing
TRPC5 (Fig. 5A). Total protein extracts from HEK-293
cells, transfected with TRPC5 cDNA, were incubated
overnight with the beads coated with biotinylated junc-
tate-Nter peptide. Fig. 5A shows that beads specifically
coated with junctate-Nter peptide retained expressed
TRPC5 protein (Fig. 5A, lane 5). On the other hand,
beads coated with biotin only did not retain TRPC5 (Fig.
5A, lane 3). Subsequently, we tested, by an identical
Fig. 6. Binding site of junctate on TRPC2 is different on IP3 receptor sites.
(A) F2q peptide prevents TRPC2 binding on calmodulin–sepharose beads
in a calcium-independent manner. Western blot of the bound fractions on
the CaM–sepharose beads with an anti-histidin antibody, showing the
binding of TRPC2. When TRPC2-Cter was incubated with CaM–
sepharose beads, TRPC2 was kept within the beads (lane 1 with [Ca2+] =
100 AM and lane 3 with [Ca2+] = 10 nM). When TRPC2-Cter is
preincubated with 20 AM F2q peptide 30 min before addition to CaM–
sepharose beads, TRPC2 was no longer holding on the beads (lane 2 with
[Ca2+] = 100 AM and lane 4 with [Ca2+] = 10 nM). Lanes are extracted from
the same gel but rearranged. (B) 25 AM junctate peptide is unable to block
TRPC2 binding on CaM–sepharose beads. Western blot of the bound
fractions on CaM–sepharose beads with an anti-histidin antibody, showing
the binding of TRPC2. When His-TRPC2-Cter was incubated with CaM–
sepharose beads, TRPC2 was kept within the beads (lane 1 with [Ca2+] =
100 AM). Preincubation with 25 AM biotinylated junctate-Nter peptide, 30
min before addition to CaM–sepharose beads, does not prevent TRPC2
binding on the beads (lane 2). (C) F2q peptide is unable to modify His-
TRPC2-Cter binding on biotinylated junctate-Nter peptide. Biotinylated
junctate-Nter peptide was first bound on streptavidin beads. Western blot of
the bound fractions on the streptavidin beads with an anti-histidin antibody,
showing the binding of TRPC2. This Western blot evidences the specific
binding of His-TRPC2-Cter on biotinylated junctate-Nter peptide immobi-
lized on streptavidin beads (lane 1). Preincubation with 20 AM F2q peptide,
30 min before addition to streptavidin beads, does not prevent TRPC2
binding on the beads (lane 2).
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By Western blot, we checked that a protein of a molecular
weight of 82 kDa is specifically evidenced in HEK-293
cells transiently transfected with TRPC1 cDNA (Fig. 5B),
using an antibody directed against TRPC1. In contrast to
what was observed with TRPC5, junctate-coated beads did
not keep TRPC1. These results show that junctate is able
to bind onto specific TRPC channel isoforms only. Thus,
junctate binds onto TRPC2 and TRPC5 but not onto
TRPC1.
TRPC2 has distinct binding sites for junctate and
IP3R/calmodulin
It has previously been shown that TRPC2 carboxyl-
terminus contains binding sites for the IP3R and calm-
odulin (CaM) (Tang et al., 2001). Tang and collaborators
characterized two binding sites for IP3R on the carboxyl-
terminus of TRPC2. The first one, localized between
amino acids 901 and 936 of TRPC2, was named CIRB
(Calmodulin IP3R Binding site) because not only IP3R,
but also CaM is able to bind to it. CaM and IP3R are in
competition at the CIRB, and a small peptide from the
IP3R, named F2v (amino acids 681–698 of the IP3R),
blocks the interaction between CIRB and CaM with an
IC50 of 21 AM. The second binding site for IP3R is
localized between amino acids 944 and 1072 of TRPC2.
Although CaM binds to the same region of the protein, no
data are available concerning mutual exclusion of IP3R
and CaM at this second binding site of TRPC2. We
attempted to determine if junctate binding site and the
IP3R and calmodulin binding sites overlap. To determine
whether junctate and IP3R share the same interaction site,
we used a peptide from the IP3R, named F2q (amino acids
669–698 of the IP3R), which is longer than F2v and
known to interact also with both IP3R binding sites of
TRPC2. In a first set of experiments, we confirmed
whether F2q is able to interact with the full carboxyl-
terminus of TRPC2 fusion protein. To check the binding of
F2q on TRPC2, we used the property of F2q to inhibit the
interaction of CaM on the CIRB sequence of TRPC2
(Tang et al., 2001).
His-TRPC2-Cter fusion protein was incubated with
calmodulin–sepharose beads, and bound proteins were
evidenced by Western blot. Fig. 6A shows that His-
TRPC2-Cter binds to CaM–sepharose in both 10 nM (lane
1) and 100 AM (lane 3) tested calcium concentrations. When
0.1 AM His-TRPC2-Cter fusion protein was preincubated
with 20 AM F2q peptide, the interaction of His-TRPC2-Cter
with CaM–sepharose was completely blocked (Fig. 6A,
lanes 2 and 4). This experiment confirms previous data
showing that F2q peptide and CaM bind to TRPC2 on a
common site (CIRB domain).
We then examined the possibility that the junctate-Nter
peptide modulates TRPC2 binding on CaM–sepharose
beads (Fig. 6B). The preincubation of His-TRPC2-Cterfusion protein with 25 AM junctate-Nter peptide did not
prevent TRPC2 binding to CaM–sepharose (Fig. 6B, lane
2). This result strongly suggests that junctate binding site
and CaM binding sites are different. We then examined the
ability of junctate to bind on TRPC2 when both IP3R
binding sites are supposedly occupied by F2q peptide (Fig.
6C): His-TRPC2-Cter fusion protein was incubated with 20
AM F2q and then challenged for the binding to streptavidin
beads coated with biotinylated junctate-Nter peptide. Fig.
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His-TRPC2-Cter binding on junctate-Nter peptide, contrary
to its action on the binding of TRPC2 onto CaM–sepharose.
These results demonstrate that the binding site of junctate on
TRPC2 is different from the common binding sites for the
IP3R and CaM.
DAG does not promote acrosome reaction
Currently, two modes for TRPC2 activation have been
proposed: via the second messenger DAG in neurons of
the vomeronasal organ or via a direct interaction with the
IP3R. The fact that TRPC2 has both IP3R and junctate as
biochemical partners does not allow rejecting the hypoth-
esis of a direct activation of TRPC2 by DAG in sperm
because activation of PLC is a necessary step during
acrosome reaction. Indeed, U73122, an inhibitor of PLC,
blocks ZP3-activated calcium influx. We evaluated the
direct effect of DAG on sperm acrosome reaction. Fig. 7
shows that 100 AM OAG does not increase the number of
acrosome-reacted sperm in comparison with a control
medium containing no specific activators of the AR (Fig.
7, bar labeled OAG versus bar labeled control). We
checked that a calcium ionophore increases the number
of acrosome-reacted sperm (Fig. 7, bar labeled A23187).
The fact that the medium used to promote capacitation
increases the level of spontaneous acrosome-reacted sperm
indicates that sperm are ready to be activated by
physiological agonists of the AR (Fig. 7, bar labeled No
Cap versus bar labeled control).Fig. 7. OAG does not promote acrosome reaction. Histograms showing the
percent of acrosome-reacted sperm cells in different conditions: 45 min
after the beginning of capacitation in a medium containing 20 mg/ml BSA,
100 AM OAG, a permeant analogue of DAG was introduced in the medium
of capacitation, and sperm were incubated for further 30 min. Three
different types of control experiments were performed: (1) sperm incubated
during 75 min in a medium with a low concentration of BSA (0.1 mg/ml)
that does not support capacitation (bar labeled No Cap), (2) sperm
incubated 75 min in the medium supporting the sperm capacitation (with
20 mg/ml BSA) (bar labeled control) and (3) sperm incubated for further 30
min with 10 AM A23187, a calcium ionophore, after an initial 45 min of
incubation in the capacitation medium (bar labeled A23187). Sperm were
then fixed and stained with coomassie G250 to assess the acrosomal status.
The number of acrosome-reacted sperm cells was determined. For each
experiment, more than 150 sperm cells have been counted, n = 3
independent experiments. The difference between OAG and control bars
is not statistically different (t test).Discussion
In this paper, we demonstrate the following points.
Firstly, in rodents, junctate is expressed in sperm and
localized in the same subcellular area as IP3R, i.e. the
acrosomal crescent of the anterior sperm head.
Secondly, junctate interacts with two TRPC, TRPC2 and
TRPC5, both channels being putatively involved in calcium
signaling during AR. In the other hands, junctate is not a
molecular partner of TRPC1, which is also present in the
sperm acrosomal crescent.
Thirdly, the amino-terminus of junctate interacts with the
carboxyl-terminus of TRPC2. The binding site of junctate
on TRPC2 is different than (1) the CIRB (Calmodulin IP3R
Binding site) IP3R binding site described earlier (Tang et al.,
2001) and (2) the calmodulin binding sites. We also
confirmed in this paper previous results regarding the
TRPC2 interaction with IP3R and calmodulin. Finally,
DAG is not sufficient to promote a significant increase of
the rate of acrosome reaction by itself.
Junctate is present in sperm
The gene coding for junctate produces also two other
proteins: junctin and aspartyl beta-hydroxylase. The three
splice variants of the same gene, junctate, junctin and
aspartyl beta-hydroxylase, have different patterns of expres-
sion and different cellular roles. Aspartyl beta-hydroxylase
is expressed at different levels in almost all tissues tested
and also in testis (Dinchuk et al., 2000). This protein is
involved in post-translational protein processing. Junctin is
expressed in cardiac and skeletal muscles (Treves et al.,
2000), in which it regulates the activation of the ryanodine
receptor. Because of the choice of the primers, both junctate
and junctin mRNA, but not aspartyl beta-hydroxylase
mRNA, were potentially amplified. However, junctin is
not expressed in non-muscle tissue (Lim et al., 2000; Treves
et al., 2000), and its expression as followed by real-time RT-
PCR is null in testis (Dinchuk et al., 2000). On the other
hand, junctate is expressed in all tissues tested, except
skeletal muscles (Hong et al., 2001; Treves et al., 2000). The
band amplified by RT-PCR in sperm should thus correspond
to junctate. The fact that we amplified only one band was
perfectly expected. The primers flank a fully conserved
sequence common to all splice variants of junctate and
junctin and should thus amplify only one band. In Western
blot experiments, the antibody used has been designed
against the non-catalytic part of the aspartyl beta-hydrox-
ylase and then recognized specifically junctate and aspartyl
beta-hydroxylase, but not junctins (Treves et al., 2000).
However, all expressed splice variants of aspartyl beta-
hydroxylase have a molecular weight higher than 60 kDa
(Dinchuk et al., 2000), and bands stained below 50 kDa
most likely correspond to junctate.
In mouse, Western blot analysis shows that the antibody
against junctate immunodecorates three bands in the range
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that Western blots reveal different bands in the range of 40–
50 kDa was not surprising since it has already been
described that there are different splice variants of junctate,
especially in mouse cardiac cells (Hong et al., 2001). This
result suggests that different isoforms of junctate are present
in mouse sperm, contrary to the rat where only one band is
stained.
In rabbit kidney, a lower weight of 32 kDa for junctate
has already been described (Treves et al., 2000). This
difference may be due to murine specific glycosylation of
junctate proteins. Indeed, the mouse cardiac isoforms show
similar apparent molecular weights in the range of 40–53
kDa, whereas their predicted MW from cDNA sequence are
23.7, 28.5 and 29.9 kDa (Hong et al., 2001), and humbug, a
truncated transcript of aspartyl beta-hydroxylase lacking the
catalytic domain, has an apparent MW of 60 kDa, whereas
its predicted MW from cDNA sequence is 35 kDa (Dinchuk
et al., 2000). This glycosylation difference may be due to
species differences since human junctate has 29 amino acids
in excess over mouse junctate. This difference may also be
due to testis-specific splice variants, as known for many
proteins that possess specific variant in testis.
Junctate binds to TRPC2 and TRPC5 but not to TRPC1
We have previously shown that junctate binds to TRPC3
(Treves et al., 2004). In this paper, we clearly showed that
TRPC2 and TRPC5 bind also to junctate. These results
suggest that junctate is an important partner of TRPC
channels. In native cells, it has been previously shown that
TRPC1 and TRPC5 form heteromers (Strubing et al., 2001)
Therefore, although junctate does not bind to TRPC1
purified from HEK-293 cells transiently transfected with aFig. 8. Model of calcium channel organization in sperm head membranes. TRPC
Calmodulin IP3R Binding sites (CIRB) allowing direct interactions either with
domain for junctate, a protein located in the acrosomal membrane and known toplasmid containing TRPC1, it is possible that, in sperm,
junctate binds to TRPC1/TRPC5 heterotetramer channels.
TRPC2 interacts with junctate by its carboxyl-terminus.
It is sensible to think that the carboxyl-terminus of other
interacting TRPC channels plays a crucial role in the
binding to junctate. The fact that TRPC1 has the shortest
C-terminus among the different TRPC channels may
suggest that the junctate binding site is not located in its
C-terminus.
Binding sites on carboxyl-terminus of TRPC2
So far, two proteins have been described to interact with
the carboxyl-terminus of TRPC2: the IP3R and calmodulin
(Tang et al., 2001). Both proteins bind onto two domains:
one is localized between amino acids 901–936 (CIRB,
domain 1) and the other domain is localized between amino
acids 944–1072 of TRPC2 (domain 2). In this study, we
describe a third protein that interacts with the carboxyl-
terminus of TRPC2, i.e. junctate. We demonstrate that the
binding site of junctate is distinct from the CIRB (domain 1)
and the domain 2. Moreover, our results give new insights
concerning IP3R and CaM bindings on TRPC2.
Firstly, from studies on TRPC4 (Tang et al., 2001), it has
been shown that there is no mutual exclusion of IP3R and
calmodulin on domain 2, contrary to the domain 1 (CIRB
domain). For TRPC2, no data are available concerning
mutual exclusion of IP3R and CaM on domain 2. If we
hypothesize that the binding of IP3R on domain 1 does not
interfere with the binding of IP3R on domain 2, the fact that
the F2q peptide completely blocks the binding of the full
carboxyl-terminus of TRPC2 on CaM–sepharose indicates
a mutual exclusion of IP3R and calmodulin on both
domains 1 and 2. Therefore, TRPC2 would present two2 is a plasma membrane channel, and its C-terminal domain possesses two
the IP3R or calmodulin. TRPC2 contains also in its C-terminus a binding
interact also with the IP3R.
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His-TRPC2-Cter on CaM–sepharose in the presence of F2q
is abolished also suggests that these two domains are the
only CaM-binding domains present in the carboxyl-termi-
nus of TRPC2. It may be important to notice that the
absence of competition between the IP3R and CaM on the
domain 2 of TRPC4 (localized between amino acids 781–
864) may be due to the fact that the competition experiments
have been performed using the shorter F2v peptide (10
amino acids shorter), instead of the F2q peptide.
Secondly, earlier studies, using a short fragment of
TRPC4, encompassing domain 1 (CIRB domain, amino
acids 901–936) showed that the binding of CaM on TRPC4
is calcium-dependent. The calcium dependence of domain 2
was not tested (Tang et al., 2001). In this paper, we tested
the full carboxyl-terminus of TRPC2, containing both CaM
domains. In our conditions, the full carboxyl-terminus of
TRPC2 binds to CaM in a calcium-independent manner.
In conclusion, we demonstrate in this study that TRPC2
behaves differently than TRPC4: firstly, the binding of F2q
on both domains 1 and 2 of TRPC2 blocks CaM binding,
and, secondly, at least one CaM binding site of TRPC2 is
calcium-independent.
TRPC2 activation
We have shown that (1) junctate is localized in the same
subcellular area as the IP3R, the acrosomal crescent of the
anterior sperm head and (2) the amino-terminus of junctate
interact with the carboxyl-terminus of TRPC2. Moreover,
we previously described that the amino-terminus of junctate
binds also to the IP3R (Treves et al., 2004). These results,
taken together, suggest that calcium signaling during the AR
involves a supramolecular complex of two calcium chan-
nels, one localized in the plasma membrane and the other
one in the outer acrosomal membrane associated with at
least two regulating proteins which are junctate and calm-
odulin (Fig. 8).
The rate of calcium increase necessary to trigger the
acrosome reaction has to be fast, and slowing this rate
abolishes the acrosome reaction (Jungnickel et al., 2001).
Because of the small volume of the cytoplasm in sperm cell
and because we used high concentration of OAG (100 AM),
intracellular OAG concentration should increase very fast.
However, this cytoplasmic burst of OAG fails to induce the
acrosome reaction. We think that this result strongly
suggests that endogenous DAG production during the
acrosome reaction is not sufficient to trigger by itself a
sudden and large TRPC2 activation, necessary for a fast rate
of calcium increase. The fact that junctate, like the IP3R,
binds to TRPC2 rather suggests that junctate and IP3R are
involved in TRPC2 activation. Indeed, we have previously
shown that junctate is able to modulate TRPC3 activation
(Treves et al., 2004) and a similar mechanism is expected
for TRPC2. This result provides a new hypothesis concern-
ing TRPC2 activation in sperm: TRPC2 activation may bedue to modifications of the bindings of both junctate and
IP3R on TRPC2 induced by store depletion.
Previous studies have shown that the gating of TRPC
channels is dependent on their level of expression in cell
lines (Vazquez et al., 2003). This work points out the
importance of studying TRPC channel activation and
regulation in the physiological context of differentiated
cells, like sperm. Indeed, as a function of its tissue
localization, TRPC2 is activated by different mechanisms:
in sperm and erythroblast, TRPC2 activation appears
dependent on store depletion, in contrast to neurons of
the vomeronasal organ, where TRPC2 activation is
dependent on an increase of DAG concentration. In sperm
and in erythroblasts, long splice variants were detected, in
contrast to neurons of the vomeronasal organ, where only
the short splice variant is expressed (Hofmann et al.,
2000). This difference in the mechanisms of activation is
not due to the absence of the IP3R binding motif in the
short splice variant since the carboxyl-termini of both
splice variants are identical. This difference is rather due to
a specific targeting of TRPC2 in sperm in microdomains
of plasma membrane specialized in interactions with the
acrosome membrane. So far, no proteins have been
described to bind to the first specific 300 amino acids of
the long splice variants of TRPC2. Enkurin, a new partner
of TRPC channels which bind to amino-terminus of TRPC
(Sutton et al., 2004), is probably not be involved in
specific targeting since this protein is expressed in both
testis and vomeronasal organ.Acknowledgments
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